Learn More:

Resources

Download Our Phosphate Binding Study
Download Our Latest White Paper

This study critically examined the efficacy of phosphate binding by a new phosphate binder, calcium succinate monohydrate (CS), under three in vitro conditions designed to mimic phosphate binding in vivo. Experimental results were compared with phosphate binding by calcium acetate (PhosLo® gelcaps), under the same conditions. 

Download Our Literature Review: Magnesium Inclusion in Phosphate Binders

GI absorption of diet-derived phosphate may be lowered and controlled by cations such as calcium and magnesium. Since both physiological metals bind phosphate, what may be observed if they are used in combination?

US8759398B2: Phosphorus Binder Composition For Treatment of Hyperphosphatemia

This BioLink patent illustrates our unique approach to addressing unmet needs and enhancing patient care. By selecting calcium succinate we identified a phosphate binder that exhibited equivalent phosphate-binding properties to calcium acetate in vitro but could not generate a volatile, irritating acid. Moreover, succinate is an integral part of human metabolism and the tricarboxylic acid cycle.

Download AHA Graphical Abstract

AHA Graphical Abstract - Magnesium Counteracts Vascular Calcification. 

About BioLink

BioLink is a specialty pharmaceutical company focused on the development and commercialization of patented treatments... Learn more here...

Learn More

Learn more about Phosveda:

How Phosveda Works

Reducing serum phosphorus levels by binding dietary phosphates in the gastrointestinal tract continues to be a focus of treatment of CKD. 

Learn more here...

Partner With Us

We believe in creating treatments that meet the needs of underserved patient populations and we are looking for companies and individuals to partner with us on our mission.

Learn more here...

On Target For Phosphate Binding

Calcium salts are effective, inexpensive, and widely used phosphate binders.

Learn more here...

Learn more about Phosveda by downloading the following resources.

Download BioLink ASN Conference Presentation Material

Information presented that the 2019 ASN Conference.

Partner With Us

At BioLink, we are always looking for terrific partners for our suite of products and patented molecules who can help us effectively reach appropriate patients and the clinicians who treat them. If you have an interest in Phosveda or any other BioLink assets, please reach out to us at info@phosveda.com or 919-678-9478.

 

Learn more here...

 
 
 
 
Download Our Latest White Paper

The information and reference materials contained in this document are intended  solely for the general education of the reader. The document is intended to provide  pertinent data to assist you in forming your own conclusions and making decisions. This document should not be considered an endorsement of the information provided nor is it intended for treatment purposes and is not a substitute for professional  evaluation and diagnosis. Additionally, this information is not intended to advocate any indication, dosage or other claim that is not covered, if applicable, in an FDA- approved label.

®

BioLink  |  250 Quade Drive  |  Cary, NC 27513  |  Phone: 1-919-678-9478  

BioLink LinkdIn